Evidence map›Paper›PMID 41073117›Full record

Observational studyBMJ open2025

Impact of COVID-19 state of emergency declarations on percutaneous coronary intervention volumes in Japan: a SARIMAX analysis of nationwide DPC database (2018-2021).

Fumio Watanabe, Keiji Muramatsu, Kei Tokutsu, Makoto Okawara, Kiyohide Fushimi, Shinya Matsuda

Abstract readObservational Study
In one paragraph

Observational study in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fumio WatanabeDepartment of Preventive Medicine and Community Health, University of Occupational and Environmental Health, Kitakyushu, Japan f_watanabe@med.uoeh-u.ac.jp.ORCID http://orcid.org/0009-0000-9186-4848
Keiji MuramatsuCenter for Next Generation of Community Health, Chiba University Hospital, Chiba, Japan.
Kei TokutsuDepartment of Preventive Medicine and Community Health, University of Occupational and Environmental Health, Kitakyushu, Japan.
Makoto OkawaraDepartment of Preventive Medicine and Community Health, University of Occupational and Environmental Health, Kitakyushu, Japan.
Kiyohide FushimiHealth Care Policy and Informatics, Institute of Science Tokyo Graduate School of Medical and Dental Sciences, Bunkyo, Japan.ORCID http://orcid.org/0000-0002-1894-0290
Shinya MatsudaDepartment of Preventive Medicine and Community Health, University of Occupational and Environmental Health, Kitakyushu, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate the impact of Japan's COVID-19 state of emergency declarations on percutaneous coronary intervention (PCI) volumes using Seasonal AutoRegressive Integrated Moving Average with eXogenous variables (SARIMAX) modelling. This model offers methodological advantages by: (1) accounting for trends, seasonal variations and autocorrelation; (2) allowing the introduction of policy intervention periods as binary exogenous variables; and (3) enabling an accurate assessment of healthcare impacts during intermittent declaration phases while accounting for periods of subsidence.

designRetrospective observational study using a SARIMAX model.

setting1377 acute care hospitals participated in Japan's Diagnosis Procedure Combination (DPC) system between April 2018 and December 2021.

participantsAll patients who underwent emergency PCI (n=176 878) or elective PCI (n=272 811) during the study period, identified from a nationwide administrative database.

interventionsThis study analysed the impact of Japan's COVID-19 state of emergency declarations as policy intervention periods, which were implemented during four waves (April to May 2020, January to March 2021, May to June 2021 and July to September 2021). Months where more than half of the days fell within a state of emergency declaration were defined as intervention periods. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcome measures were nationwide changes in both emergency and elective PCI volumes during state of emergency periods compared with non-emergency periods, analysed through SARIMAX modelling. Secondary outcomes included regional analyses of changes in both types of PCI volumes across eight geographical regions of Japan and the distribution analysis of medical resources (DPC hospitals, hospital beds, physicians and board-certified cardiologists per million population) in each region.

resultsNationwide, emergency PCI volumes totalled 176 878 and elective PCI volumes 272 811 over the 45-month study period. SARIMAX modelling indicated that the state of emergency declarations were associated with significant reductions in both emergency PCI volumes (-211.4 cases/month, 95% CI -326.9 to -95.9; -5.4%) and elective PCI volumes (-632.4 cases/month, 95% CI -1045.9 to -219.0; -10.4%). Regional analyses showed varied effects, with some areas (eg, Hokkaido, Shikoku, Kyushu) experiencing non-significant volume decreases, potentially reflecting differences in medical resource distribution and capacity.

conclusionsThe COVID-19 state of emergency declarations in Japan were associated with decreased PCI volumes. Applying SARIMAX models to real-world data could allow us to examine the effects of various events on healthcare considering trends, seasonal variation and autocorrelation by incorporating events as exogenous variables.

Indexed as

COVID-19Percutaneous Coronary InterventionAgedDatabases, FactualFemaleHumansJapanMaleRetrospective StudiesSARS-CoV-2Coronary heart diseaseCoronary interventionCOVID-19Health Services Accessibility

Identifiers

PMID41073117
PMCPMC12542588

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.